CAS No 95635-55-5 RANOLAZINE Pharmaceutical Intermediates
Overview
Ranolazine is an innovative antianginal drug mainly used to treat chronic stable angina.
Its mechanism of action is to improve blood flow to the myocardium, thereby reducing the frequency of angina attacks. Unlike traditional antianginal therapies, ranolazine does not significantly affect heart rate or blood pressure, making it a unique option for patients who have not responded well to other therapies.
Its mechanism of action includes inhibition of late sodium currents, which helps reduce myocardial oxygen demand and improves overall cardiac function.
Physical and chemical properties
- Solubility: Soluble in organic solvents such as methanol and dimethyl sulfoxide (DMSO), slightly soluble in water, and easy to prepare into various dosage forms.
- STABILITY: Ranolazine exhibits good stability under recommended storage conditions, ensuring longer shelf life and reliability in therapeutic applications.
These properties make ranolazine suitable for formulating a variety of pharmaceutical products, including tablets and extended-release formulations.
1. UNIQUE MECHANISM OF ACTION: Ranolazine's ability to target late sodium currents provides a unique therapeutic approach, making it effective in patients with chronic stable angina who may not respond to conventional treatments.
2. MINIMAL SIDE EFFECTS: Unlike many other antianginal drugs, ranolazine does not significantly affect heart rate or blood pressure, making it a safer option for a wider range of patients.
3. Improve quality of life: Clinical studies have shown that ranolazine can enhance exercise tolerance and reduce the frequency of angina attacks, thereby improving patients' quality of life.
4. Regulatory Compliance: Our RANOLAZINE is manufactured in accordance with international pharmaceutical standards, ensuring that it meets the stringent requirements set by health authorities.
As a production and trading integrated factory, we are committed to providing customers with high quality Ranolazine. Our dedication to quality is reflected in our advanced manufacturing processes and strict quality control measures.
- Expertise: Our team of professionals is dedicated to research and development, ensuring we remain at the forefront of pharmaceutical innovation.
- Customer-centric approach: We prioritize our clients' needs, providing customized solutions and responsive customer service to support their specific needs.
- Sustainability: We are committed to using sustainable practices in our manufacturing processes to ensure we maintain product quality while minimizing our impact on the environment.
In conclusion, RANOLAZINE is an important pharmaceutical ingredient that may provide numerous benefits in the treatment of chronic stable angina. With our combined production capabilities, high quality standards and commitment to customer satisfaction, we are your ideal partner in the pharmaceutical industry.
Choose our RANOLAZINE as your formula and experience the difference in quality and efficacy. For inquiries or to place an order, please contact us today!